Cargando…

Case Report: The Complexities of Managing Medications and the Importance of Deprescribing Anticholinergics in Older Adults

Potentially inappropriate anticholinergic medications (including over-the-counter products), polypharmacy, and the existence of communication barriers among members of the interprofessional team frequently contribute to clinical complexity in older adults. We present the case of a frail 86-year old...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elliott, Taylor, Eckmann, Lynne, Moga, Daniela C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087073/ https://www.ncbi.nlm.nih.gov/pubmed/33935693 http://dx.doi.org/10.3389/fphar.2021.584667

Ejemplares similares

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
por: Soiza, Roy L., et al.
Publicado: (2021)

Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden
por: Moga, Daniela C., et al.
Publicado: (2017)

A Prescribing Cascade of Proton Pump Inhibitors Following Anticholinergic Medications in Older Adults With Dementia
por: Trenaman, Shanna C., et al.
Publicado: (2022)

Barriers and Enablers of Older Patients to Deprescribing of Cardiometabolic Medication: A Focus Group Study
por: Crutzen, Stijn, et al.
Publicado: (2020)

Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia
por: Hsieh, Stephanie, et al.
Publicado: (2021)

Deprescribing anticholinergics in primary care older adults: Experience from two models and impact on a continuous measure of exposure
por: Campbell, Noll L., et al.
Publicado: (2022)

Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
por: Jamieson, Hamish, et al.
Publicado: (2023)

One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults
por: Martinez, Ashley I., et al.
Publicado: (2020)

Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021)

Potential Targets for Deprescribing in Medically Complex Older Adults with Suspected Cognitive Impairment
por: Pavon, Juliessa M., et al.
Publicado: (2022)

High anticholinergic burden at admission associated with in‐hospital mortality in older patients: A comparison of 19 different anticholinergic burden scales
por: Lisibach, Angela, et al.
Publicado: (2021)

The Prognostic Value of Anticholinergic Burden Measures in Relation to Mortality in Older Individuals: A Systematic Review and Meta-Analysis
por: Graves-Morris, Katherine, et al.
Publicado: (2020)

Educating Homecare Nurses about Deprescribing of Medications to Manage Polypharmacy for Older Adults
por: Sun, Winnie, et al.
Publicado: (2021)

Factors Important to Older Adults Who Disagree With a Deprescribing Recommendation
por: Weir, Kristie Rebecca, et al.
Publicado: (2023)

Exposure to anticholinergic and sedative medication is associated with impaired functioning in older people with vertigo, dizziness and balance disorders—Results from the longitudinal multicenter study MobilE-TRA
por: Katzenberger, Benedict, et al.
Publicado: (2023)

The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition
por: Oh, GYeon, et al.
Publicado: (2022)

Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications
por: Kouladjian O’Donnell, Lisa, et al.
Publicado: (2019)

Potentially inappropriate medication and attitudes of older adults towards deprescribing
por: Achterhof, Alexandra B., et al.
Publicado: (2020)

A pharmacist-led medication review service with a deprescribing focus guided by implementation science
por: Alaa Eddine, Nada, et al.
Publicado: (2023)

Dataset on cost-analysis of medication deprescribing scenarios for older adult coverage under public drug benefit programs in Canada
por: Fadaleh, Sarah Abu, et al.
Publicado: (2020)

Older adults’ exposure to anticholinergic medications: Implications for pharmaceutical care for Nigerian older adults
por: Okoro, Roland Nnaemeka, et al.
Publicado: (2022)

Attitudes of Older Adult Patients and Caregivers Towards Deprescribing of Medications in Ethiopia
por: Gadisa, Diriba Alemayehu, et al.
Publicado: (2023)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
por: Ailabouni, Nagham, et al.
Publicado: (2017)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

AN EXPLORATION OF HOME CARE NURSES’ EXPERIENCES IN DEPRESCRIBING OF MEDICATIONS FOR OLDER ADULTS IN THE COMMUNITY
por: Sun, Winnie
Publicado: (2019)

Older people’s attitudes towards deprescribing cardiometabolic medication
por: Crutzen, Stijn, et al.
Publicado: (2021)

VULNERABILITY TO ANTICHOLINERGIC MEDICATION ASSOCIATED FRAILTY IN LOW-INCOME MINORITY OLDER ADULTS
por: Sargent, Lana, et al.
Publicado: (2022)

Cognitive Decline in Older Persons Initiating Anticholinergic Medications
por: Shah, Raj C., et al.
Publicado: (2013)

Antihypertensive Deprescribing in Older Adults: a Practical Guide
por: Sheppard, James P., et al.
Publicado: (2022)

Are Anticholinergic Symptoms a Risk Factor for Falls in Older General Practice Patients With Polypharmacy? Study Protocol for the Development and Validation of a Prognostic Model
por: Dinh, Truc Sophia, et al.
Publicado: (2021)

Measuring cumulative anticholinergic medicines burden in older Australian women
por: Parkinson, Lynne, et al.
Publicado: (2017)

Deprescribing medications for older adults in the primary care context: A mixed studies review
por: Gillespie, Robyn J., et al.
Publicado: (2018)

Deprescribing in Older Adults: Is Evidence for Continued Medication Use Generalizable Beyond Age 75?
por: Niznik, Joshua
Publicado: (2020)

Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists
por: Lukacena, Kaylee M., et al.
Publicado: (2022)

Anticholinergic Drugs Interact With Neuroprotective Chaperone L-PGDS and Modulate Cytotoxicity of Aβ Amyloids
por: Low, Kimberly Jia Yi, et al.
Publicado: (2020)

Older Adults’ Awareness of Deprescribing: A Population‐Based Survey
por: Turner, Justin P., et al.
Publicado: (2017)

The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people
por: Todd, Adam, et al.
Publicado: (2018)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall
por: Wong, Ho Lun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_svosk8ll76sjseduod13rfrum9